Trial Profile
Phase II study of oral S-1 plus oral leucovorin in patients with previously treated non-small-cell lung cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 Aug 2017
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Folinic acid
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 23 Aug 2017 Status changed from active, no longer recruiting to completed.
- 03 Mar 2014 New trial record